Skip to main content

Table 3 Prevalence of HCV Genotype according to risk factors among Libyan population, * P = 0.26

From: Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission

Risks exposure

Genotype 1

Genotype 2

Genotype 3

Genotype 4

Total

P value*

Sexual

 No

551 (37.3)

225 (15.2)

234 (15.8)

467 (31.6)

1,477

0.424

 Yes

11 (45.8)

1 (4.2)

5 (20.8)

7 (29.2)

24

Cesarean section

 No

549 (37.7)

222 (15.2)

235 (16.1)

451 (31.0)

1,457

0.26

 Yes

13 (29.5)

4 (9.1)

4 (9.1)

23 (52.3)

44

Intravenous drug use

 No

497 (36.3)

226 (16.5)

196 (14.3)

450 (32.9)

1,369

0.000

 Yes

65 (49.2)

0 (0)

43 (32.6)

24 (18.2)

132

Blood transfusion

 No

420 (37.1)

167 (14.8)

196 (17.3)

348 (30.8)

1,131

0.071

 Yes

142 (38.4)

59 (15.9)

43 (11.6)

126 (34.1)

370

Surgery

 No

457 (38.1)

171 (14.3)

198 (16.5)

372 (31.1)

1,198

0.165

 Yes

105 (34.7)

55 (18.2)

41 (13.5)

102 (33.7)

303

Dental procedure

 No

490 (37.5)

193 (14.8)

204 (15.6)

418 (32.0)

1,305

0.641

 Yes

72 (36.7)

33 (16.8)

35 (17.9)

56 (28.6)

196

Intrafamilial

 No

549 (37.4)

222 (15.1)

232 (15.8)

463 (31.6)

1,466

0.876

 Yes

13 (37.1)

4 (11.4)

7 (20.0)

11 (31.4)

35

Haemodialysis

 No

551 (37.5)

225 (15.3)

234 (15.9)

460 (31.3)

1,470

0.185

 Yes

11 (35.5)

1 (3.2)

5 (16.1)

14 (45.2)

31